Breaking News | GenomeWeb

Breaking News

Following an inter partes review requested by 10x Genomics, the Patent Trial and Appeal Board invalidated a number of claims in a RainDance patent.

Through the deal, Ginkgo has picked up Gen9's manufacturing platform and suite of proprietary technologies, software, and informatics tools for DNA synthesis and assembly.

The firm will sell 855,000 shares of its common stock to three investors. It will also sell warrants to the same investors.

The firm has asked the SEC to withdraw a registration statement for a previously planned $8 million equity financing, saying it no longer needs the financing.

The firms will continue to develop strains of algae that demonstrate improved photosynthetic efficiency and oil production.

The deal covers Interpace's ThyGenX and ThyraMir tests for thyroid cancer, as well as its PancraGen pancreatic cancer test.

The researchers used both targeted and exome sequencing to genetically diagnose patients.

The deal is expected to strengthen WuXi Apptec's capabilities in target validation, as well as lead discovery and optimization.

The bank rated companies like Thermo Fisher Scientific and Agilent at Buy, Illumina and PerkinElmer at Hold, and Myriad Genetics and Luminex at Sell.

FilmArray drove business growth in molecular biology, contributing €80 million to Q4 revenues and €249 million to FY 2016 revenues. 

An international team of researchers examined differential gene expression in blood samples from patients infected during the West African outbreak.

At the Plant and Animal Genomes conference, a Cold Spring Harbor Lab researcher provided information on an upcoming study of maize regulatory elements.

The repurchase is part of a commitment announced by the company in July 2016 to return $300 million to shareholders by the end of 2017.

The project aims to elucidate markers of response and non-response to current treatment regimens, and to identify new therapies.

The agency expects existing programs to guide its regulation, adding that modified portions of animal genomes would be considered drugs.

DoE scientists said the data could be used to link DNA variations to phenotypes in the trees, and could even be useful for Cancer Moonshot researchers.

The researchers applied their so-called GWAX approach to study 12 common diseases in almost 120,000 individuals, confirming known and uncovering novel disease risk loci.

The deal is expected to help Takara Bio Group expand its presence in next-generation sequencing library preparation and other markets.

The collaborators will explore the use of cell-free DNA for preimplantation genetic testing. 

Caris will be on the lookout for pancreatic cancer patients with low DNA mismatch repair protein expression. 

The Cognitive Genomics Consortium researchers said their findings could help understand how the brain works at the molecular level.

ConfirmMDx is an epigenetic tissue-based test for the early detection of prostate cancer, specifically aimed at addressing false-negative biopsy concerns.

Pages

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.